Expression of Met and/or its ligand HGF increases during progression of HNSCC and there is a substantial increase of Met levels in affected lymph nodes, compared to corresponding primary tumors [82,83,84,87,88]. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.